<--- Back to Details
First PageDocument Content
Pharmacology / Dipeptidyl peptidase-4 inhibitors / Amides / Dow Jones Industrial Average / Merck & Co. / Readington /  New Jersey / Sitagliptin / Metformin / Diabetes mellitus / Medicine / Anti-diabetic drugs / Chemistry
Date: 2014-10-08 00:16:31
Pharmacology
Dipeptidyl peptidase-4 inhibitors
Amides
Dow Jones Industrial Average
Merck & Co.
Readington
New Jersey
Sitagliptin
Metformin
Diabetes mellitus
Medicine
Anti-diabetic drugs
Chemistry

*JANUVIA™ is the proposed trademark for MK-431 (sitagliptin phosphate)

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

Download Document from Web Archive

File Size: 167,90 KB